A.G.E. Interrupter
A high-concentration anti-wrinkle cream formulated to improve the visible signs of ageing caused by advanced glycation end-products (A.G.E.). Ideal for normal and dry skin types, this anti-ageing cream is formulated with an unprecedented 30% concentration of proxylane, 4% blueberry extract, and 0.2% phytosphingosine to improve the appearance of wrinkling and restore the loss of firmness caused by the glycation process. This cream helps reduce the appearance of skin thinning and visibly improves the appearance of fine lines, wrinkles, and skin texture. Once or twice daily, massage a thin, even layer onto the entire face, neck, and chest. Paraben, alcohol, and dye-free.
A high-concentration anti-wrinkle cream formulated to improve the visible signs of ageing caused by advanced glycation end-products (A.G.E.). Ideal for normal and dry skin types, this anti-ageing cream is formulated with an unprecedented 30% concentration of proxylane, 4% blueberry extract, and 0.2% phytosphingosine to improve the appearance of wrinkling and restore the loss of firmness caused by the glycation process. This cream helps reduce the appearance of skin thinning and visibly improves the appearance of fine lines, wrinkles, and skin texture. Once or twice daily, massage a thin, even layer onto the entire face, neck, and chest. Paraben, alcohol, and dye-free.
A high-concentration anti-wrinkle cream formulated to improve the visible signs of ageing caused by advanced glycation end-products (A.G.E.). Ideal for normal and dry skin types, this anti-ageing cream is formulated with an unprecedented 30% concentration of proxylane, 4% blueberry extract, and 0.2% phytosphingosine to improve the appearance of wrinkling and restore the loss of firmness caused by the glycation process. This cream helps reduce the appearance of skin thinning and visibly improves the appearance of fine lines, wrinkles, and skin texture. Once or twice daily, massage a thin, even layer onto the entire face, neck, and chest. Paraben, alcohol, and dye-free.
